Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on July 24, 2014, to announce its financial results for the second quarter of 2014. The filing primarily serves to furnish the press release detailing these results (Exhibit 99.1) and additional supplemental information available on the company's website (Exhibit 99.2). Investors should refer to these exhibits for the specific financial performance and operational updates from the second quarter. While the 8-K itself does not contain the detailed financial figures, it signifies the official release of BMY's Q2 2014 performance data. This information is crucial for understanding the company's revenue, profitability, and any key business developments that occurred during the quarter, which would have been presented in the accompanying press release and supplemental materials.
Key Highlights
- 1BMY released its Q2 2014 financial results on July 24, 2014.
- 2The 8-K filing officially incorporates the Q2 2014 earnings press release (Exhibit 99.1).
- 3Supplemental financial and business information is also provided via Exhibit 99.2 from the company's website.
- 4Investors are directed to the provided exhibits for detailed Q2 2014 financial performance.
- 5This filing marks the public disclosure of the company's operational and financial condition for the second quarter of 2014.